S754 Risankizumab as Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease Who Failed 1 vs >1 Prior Biologic Treatment: Results From the MOTIVATE Study. (October 2021) - Panaccione, Remo; Schreiber, Stefan; Peyrin-Biroulet, Laurent; Loftus, Edward V.; Dubinsky, Marla; Ferrante, Marc; Song, Alexandra; Huang, Bidan; Liao, Xiaomei; Berg, Sofie; Duan, Weijiang R; Wallace, Kori; et al.